Moore Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
Other funds holding GCVRZ
SCM
MCM
GCM
MFP
Moore Capital Management's GCVRZ Position: Q4 2016 in Review
Moore Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2016, closing a stake of 745,100 shares — an estimated $199K sold.
Moore Capital Management first reported a position in GCVRZ in Q2 2015 and held it in 6 quarters. The position peaked at $693K in Q2 2015. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.
- Moore Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2016 after selling out during the quarter.
- Moore Capital Management sold 745,100 Sanofi Contingent Value Rights shares in Q4 2016, an estimated $199K.
- Moore Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2015 and held it in 6 quarters.
- Moore Capital Management's Sanofi Contingent Value Rights position peaked at $693K in Q2 2015.
- 120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.
Based on Moore Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.